These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 16735132)
21. Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications. Helm L Future Med Chem; 2010 Mar; 2(3):385-96. PubMed ID: 21426173 [TBL] [Abstract][Full Text] [Related]
22. Multilocus binding increases the relaxivity of protein-bound MRI contrast agents. Zhang Z; Greenfield MT; Spiller M; McMurry TJ; Lauffer RB; Caravan P Angew Chem Int Ed Engl; 2005 Oct; 44(41):6766-9. PubMed ID: 16173108 [No Abstract] [Full Text] [Related]
23. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099 [TBL] [Abstract][Full Text] [Related]
24. Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging. Aime S; Anelli L; Botta M; Brocchetta M; Canton S; Fedeli F; Gianolio E; Terreno E J Biol Inorg Chem; 2002 Jan; 7(1-2):58-67. PubMed ID: 11862541 [TBL] [Abstract][Full Text] [Related]
25. A high-frequency EPR study of frozen solutions of Gd(III) complexes: straightforward determination of the zero-field splitting parameters and simulation of the NMRD profiles. Benmelouka M; Van Tol J; Borel A; Port M; Helm L; Brunel LC; Merbach AE J Am Chem Soc; 2006 Jun; 128(24):7807-16. PubMed ID: 16771494 [TBL] [Abstract][Full Text] [Related]
30. Early experience of paramagnetic tracers in ultra low magnetic fields. Paajanen H Acta Radiol Suppl; 1990; 374():81-3. PubMed ID: 1966974 [TBL] [Abstract][Full Text] [Related]
31. B0 dependence of the on-resonance longitudinal relaxation time in the rotating frame (T1rho) in protein phantoms and rat brain in vivo. Mäkelä HI; De Vita E; Gröhn OH; Kettunen MI; Kavec M; Lythgoe M; Garwood M; Ordidge R; Kauppinen RA Magn Reson Med; 2004 Jan; 51(1):4-8. PubMed ID: 14705038 [TBL] [Abstract][Full Text] [Related]
32. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Port M; Idée JM; Medina C; Robic C; Sabatou M; Corot C Biometals; 2008 Aug; 21(4):469-90. PubMed ID: 18344005 [TBL] [Abstract][Full Text] [Related]
33. Macromolecular contrast agents for magnetic resonance imaging. Influence of polymer content in ligand on the paramagnetic properties. Rebizak R; Schaefer M; Dellacherie E Eur J Pharm Sci; 1999 Feb; 7(3):243-8. PubMed ID: 9845812 [TBL] [Abstract][Full Text] [Related]
38. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749 [TBL] [Abstract][Full Text] [Related]
39. 1H NMRD profiles and ESR lineshapes of Gd(III) complexes: a comparison between the generalized SBM and the stochastic Liouville approach. Zhou X; Westlund PO J Magn Reson; 2005 Mar; 173(1):75-83. PubMed ID: 15705515 [TBL] [Abstract][Full Text] [Related]
40. The role of molecular conformation on tumor uptake of polymeric contrast agents. Uzgiris E Invest Radiol; 2004 Mar; 39(3):131-7. PubMed ID: 15076004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]